Drug intelligence / Profile preview

Wu Lin San

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

Wu Lin San is a Traditional Chinese Medicine (TCM) formula primarily utilized for the treatment of urinary system disorders, including cystitis, urethritis, and gonorrhea (specifically for patterns described as heat strangury). In clinical settings, it is often administered as a concentrated extract product (CEP). The formula is composed of several herbal ingredients, typically including Gui Zhi (Cinnamomi Ramulus), Fu Ling (Poria), Zhu Ling (Polyporus), Ze Xie (Alismatis Rhizoma), and Bai Ju (likely Atractylodis Macrocephalae Rhizoma), which exhibit bi-directional regulatory functions for body fluids and saliva. Pharmacological research has demonstrated that Wu Lin San can ameliorate bladder hyperactivity and inflammation by inhibiting neutrophil NADPH oxidase activity and reducing the production of reactive oxygen species (ROS). It is also being investigated for its efficacy in treating clozapine-induced hypersalivation in patients with schizophrenia.

Other names
WLS
02

Targets

NOX4 (NADPH oxidase 4)

Beyond the preview

Go deeper on Wu Lin San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wu Lin San.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call